Greater Hampstead Family Medicine, Inc. | |
207 Stage Rd Hampstead NH 03841-2224 | |
(603) 329-5222 | |
(603) 329-8016 |
Full Name | Greater Hampstead Family Medicine, Inc. |
---|---|
Speciality | Family Medicine |
Location | 207 Stage Rd, Hampstead, New Hampshire |
Authorized Official Name and Position | Nicholas Vailas (OWNER) |
Authorized Official Contact | 6032324513 |
Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
Mailing Address | Practice Location Address |
---|---|
Greater Hampstead Family Medicine, Inc. 55 Bridge Street Machester NH 03101 Ph: (603) 232-4513 | Greater Hampstead Family Medicine, Inc. 207 Stage Rd Hampstead NH 03841-2224 Ph: (603) 329-5222 |
NPI Number | 1740379940 |
---|---|
Provider Enumeration Date | 10/12/2006 |
Last Update Date | 05/06/2023 |
Medicare PECOS PAC ID | 4284734351 |
---|---|
Medicare Enrollment ID | O20070703000454 |
News Archive
In Poland, alcohol dependence (AD) affects about four percent of the population, causing about 10,000 deaths per year.
Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
› Verified 7 days ago
Identifier | Type | State | Issuer |
---|---|---|---|
1740379940 | NPI | - | NPPES |
1558350223 | Other | DR CAMMILLERI'S NPI |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 8735 (New Hampshire) | Primary |
Provider Name | Alan M Stein |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1740279256 PECOS PAC ID: 2860466133 Enrollment ID: I20040823000875 |
News Archive
In Poland, alcohol dependence (AD) affects about four percent of the population, causing about 10,000 deaths per year.
Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
› Verified 7 days ago
Provider Name | Thomas J Cammilleri |
---|---|
Provider Type | Practitioner - Family Practice |
Provider Identifiers | NPI Number: 1558350223 PECOS PAC ID: 3971521105 Enrollment ID: I20051107000520 |
News Archive
In Poland, alcohol dependence (AD) affects about four percent of the population, causing about 10,000 deaths per year.
Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
› Verified 7 days ago
Provider Name | Sarah L Shadallah |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1902142367 PECOS PAC ID: 9436303013 Enrollment ID: I20130207000012 |
News Archive
In Poland, alcohol dependence (AD) affects about four percent of the population, causing about 10,000 deaths per year.
Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
› Verified 7 days ago
Provider Name | Audrey Morgan |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1124403332 PECOS PAC ID: 7416265855 Enrollment ID: I20151005000228 |
News Archive
In Poland, alcohol dependence (AD) affects about four percent of the population, causing about 10,000 deaths per year.
Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
› Verified 7 days ago
Provider Name | Denise Poudrier Normandin |
---|---|
Provider Type | Practitioner - Registered Dietitian Or Nutrition Professional |
Provider Identifiers | NPI Number: 1104091578 PECOS PAC ID: 0446599534 Enrollment ID: I20190307002141 |
News Archive
In Poland, alcohol dependence (AD) affects about four percent of the population, causing about 10,000 deaths per year.
Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
› Verified 7 days ago
Provider Name | Lauren Cronin |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1427605377 PECOS PAC ID: 8224463757 Enrollment ID: I20200110001327 |
News Archive
In Poland, alcohol dependence (AD) affects about four percent of the population, causing about 10,000 deaths per year.
Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
› Verified 7 days ago
Provider Name | Crista Pehl |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1740855576 PECOS PAC ID: 4981009818 Enrollment ID: I20210816002652 |
News Archive
In Poland, alcohol dependence (AD) affects about four percent of the population, causing about 10,000 deaths per year.
Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
› Verified 7 days ago
Provider Name | Kathleen Devejian |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1528579257 PECOS PAC ID: 0648532499 Enrollment ID: I20230302001778 |
News Archive
In Poland, alcohol dependence (AD) affects about four percent of the population, causing about 10,000 deaths per year.
Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
› Verified 7 days ago
Provider Name | Lindsay Jones |
---|---|
Provider Type | Practitioner - Nurse Practitioner |
Provider Identifiers | NPI Number: 1972284271 PECOS PAC ID: 3375990807 Enrollment ID: I20231106001482 |
News Archive
In Poland, alcohol dependence (AD) affects about four percent of the population, causing about 10,000 deaths per year.
Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
› Verified 7 days ago
News Archive
In Poland, alcohol dependence (AD) affects about four percent of the population, causing about 10,000 deaths per year.
Almost one in four patients (24%) with advanced lung cancer in Europe, Asia and the US are not receiving EGFR test results before being started on treatment, researchers report at the European Lung Cancer Conference.
Corventis, Inc., a developer of wireless cardiovascular solutions designed to enable early detection, prevention and treatment of cardiovascular conditions, announced CE marking for the company's AVIVO™ Mobile Patient Management System. Physicians and patients in the European Union and other countries that accept CE Mark now have access to the company's noninvasive, wireless solution to evaluate physiological changes and monitor signs of cardiac irregularities in patients away from the hospital.
Cancer researchers at Princess Margaret Hospital have discovered that the ovarian hormone progesterone plays a pivotal role in altering breast stem cells, a finding that has important implications for breast cancer risk.
› Verified 7 days ago
William R Hart Md Pc Primary Care Clinic Medicare: Not Enrolled in Medicare Practice Location: 13 Emerson Ave, Hampstead, NH 03841 Phone: 603-329-6911 Fax: 603-329-5712 |